Intra-arterial chemotherapy for the treatment of retinoblastoma / 眼科新进展
Recent Advances in Ophthalmology
; (6): 385-388, 2018.
Article
em Zh
| WPRIM
| ID: wpr-699627
Biblioteca responsável:
WPRO
ABSTRACT
Intra-arterial chemotherapy (IAC) refers to the injection of chemotherapeutics into patients' eyes through arteria ophthalmica in order to local chemotherapy for retinoblastoma (RB).The common drugs in the treatment of RB include melphalan,topotecan and carboplatin.IAC can form the high-concentration drug effects on local areas.It can effectively kill tumors and significantly reduce the occurrence rate of complications after intravenous chemotherapy.Application of IAC can cure patients with RB in B,C,D and E stage in international criteria,which can effectively improve eye protection rate.Complications of IAC include eyelids edema,chemosis,blepharoptosis,ocular motility disorders,vitreous hemorrhage,ischemia of choroid or retina,transient myelosuppression,etc.It should be further conduction of long-term and large-sample cases studies on how to improve curative effects and reduce serious eye complications.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Recent Advances in Ophthalmology
Ano de publicação:
2018
Tipo de documento:
Article